scispace - formally typeset
B

Bonny Y

Researcher at Université de Montréal

Publications -  29
Citations -  573

Bonny Y is an academic researcher from Université de Montréal. The author has contributed to research in topics: Bone marrow & Transplantation. The author has an hindex of 14, co-authored 29 publications receiving 567 citations.

Papers
More filters
Journal Article

Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host disease.

TL;DR: Molecular monitoring of the fate of host/donor hematopoietic cells in the early posttransplantation period could be useful in differentiating patients with delayed engraftment from those with irreversible rejection and in predicting the occurrence of GVHD as soon as day 10.
Journal ArticleDOI

Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis : correction of the phenotype after bone marrow transplant

TL;DR: Because osteoblasts were still of recipient origin post-BMT, this suggests that functional osteoclasts, due to the replacement of hematopoeitic cells, provided a local microenvironment in vivo triggering the differentiation and/or recruitment of a limited number of functional osteoblast.
Journal ArticleDOI

Lymphoid interstitial pneumonia after allogeneic bone marrow transplantation. A possible manifestation of chronic graft-versus-host disease.

TL;DR: The data suggest that LIP in marrow‐grafted patients with chronic graft‐versus‐host disease (GVHD) who presented with late‐onset IP 242 and 632 days posttransplant may be a manifestation of chronic GVHD.
Journal ArticleDOI

Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease.

TL;DR: It is demonstrated that host LC usually persist for 39 and up to 120 d following bone marrow transplantation and the relevance of this observation to the possible role of LC and other host dendritic antigen‐presenting cells in the graft‐versus‐host reaction is discussed.
Journal ArticleDOI

Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.

TL;DR: The persistence of PCR-detectable bcr-abl-positive cells early post-BMT in more than 80% of patients suggests that neither BMT preparative regimen effectively eradicates CML cells in most patients.